Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today

Group 1: Growth Stocks Overview - Investing in growth stocks can yield significant returns over time, with some stocks providing rapid payoffs [1] - Notable growth stocks include Strategy, Mara Holdings, and Verona Pharma, which have shown impressive gains over the past five years [2] Group 2: Strategy (formerly MicroStrategy) - A $15,000 investment in Strategy five years ago would now be worth approximately $458,000, despite a decline in its core technology business [4] - Strategy is the largest corporate holder of Bitcoin, with over 500,000 coins, and its stock performance is closely tied to Bitcoin's market value [5] - The stock is considered highly speculative, with its valuation contingent on the strength of the cryptocurrency market [6] Group 3: Mara Holdings - A $15,000 investment in Mara Holdings would have grown to about $290,000 over the past five years, despite a significant drop in value since early 2022 [7] - The company's financial performance has been volatile, with losses exceeding $694 million in 2022 and a profit of $541 million in 2024, heavily influenced by the market value of Bitcoin [8] - Similar to Strategy, Mara's valuation is speculative and depends on Bitcoin's performance [9] Group 4: Verona Pharma - A $15,000 investment in Verona Pharma would now be worth $267,000, contributing to a total portfolio value of around $1.02 million when combined with the other two stocks [10] - The stock gained momentum after FDA approval for Ohtuvayre, a treatment for chronic obstructive pulmonary disease, which analysts predict could generate over $1 billion in annual revenue by 2029 [11] - Despite incurring a loss of over $173 million last year, Verona is on a positive trajectory with Ohtuvayre beginning to generate sales, making it a more attractive investment option [12]